![Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data | SpringerLink Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-016-0404-x/MediaObjects/40263_2016_404_Fig1_HTML.gif)
Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data | SpringerLink
Full article: Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data
![Consumer-driven health insurance in Switzerland, where politics is governed by federalism and direct democracy (Chapter 14) - Private Health Insurance Consumer-driven health insurance in Switzerland, where politics is governed by federalism and direct democracy (Chapter 14) - Private Health Insurance](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200930043822822-0882:9781139026468:12582fig14_3b.png?pub-status=live)
Consumer-driven health insurance in Switzerland, where politics is governed by federalism and direct democracy (Chapter 14) - Private Health Insurance
![IJERPH | Free Full-Text | Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational IJERPH | Free Full-Text | Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational](https://pub.mdpi-res.com/ijerph/ijerph-19-07922/article_deploy/html/images/ijerph-19-07922-g001.png?1656490500)
IJERPH | Free Full-Text | Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational
![Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland - Oliver Gruebner, Wenjia Wei, Agne Ulyte, Viktor von Wyl, Holger Dressel, Beat Brüngger, Caroline Bähler, Eva Blozik, Matthias Schwenkglenks, Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland - Oliver Gruebner, Wenjia Wei, Agne Ulyte, Viktor von Wyl, Holger Dressel, Beat Brüngger, Caroline Bähler, Eva Blozik, Matthias Schwenkglenks,](https://journals.sagepub.com/cms/10.1177/23333928221097741/asset/images/large/10.1177_23333928221097741-fig2.jpeg)
Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland - Oliver Gruebner, Wenjia Wei, Agne Ulyte, Viktor von Wyl, Holger Dressel, Beat Brüngger, Caroline Bähler, Eva Blozik, Matthias Schwenkglenks,
![PDF) Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland PDF) Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland](https://i1.rgstatic.net/publication/334117637_Hospital_readmission_risk_prediction_based_on_claims_data_available_at_admission_a_pilot_study_in_Switzerland/links/5d180be2299bf1547c893008/largepreview.png)
PDF) Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study | PLOS ONE
![Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database - Huber - 2020 - Pharmacoepidemiology and Drug Safety - Wiley Online ... Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database - Huber - 2020 - Pharmacoepidemiology and Drug Safety - Wiley Online ...](https://onlinelibrary.wiley.com/cms/asset/056e9409-8bf8-47cf-bd04-d75fec8c3dfc/pds4938-fig-0001-m.jpg)
Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database - Huber - 2020 - Pharmacoepidemiology and Drug Safety - Wiley Online ...
![Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study | BMC Public Health | Full Text Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12889-020-10079-8/MediaObjects/12889_2020_10079_Fig1_HTML.png)